Showing results (2251-2260 of 10,080) with videos related to

Sort By:
Pageof 1,008
Current Pharmaceutical Design|July 18, 2024
Nanotechnological Advances in the Diagnosis of Gynecological Cancers and NanotheranosticsVahideh Keyvani, Samaneh Mollazadeh, Espanta Riahi, et al.
Current Pharmaceutical Design|July 4, 2024
The Relationship between SNAP25 and Some Common Human Neurological SyndromesJie Shu, Fan Peng, Jing Li, et al.
Current Pharmaceutical Design|July 4, 2024
Total Flavonoids Isolated from the Leaves of Eucommia ulmoides Augment Peak Bone Mass in Female Rats and Show no Side Effects in Other OrgansYun Zhang, Mingzhen Yang, Ningli Li, et al.
Current Pharmaceutical Design|July 11, 2024
Treatment of Patients with IgA Nephropathy: Evaluation of the Safety and Efficacy of Mycophenolate MofetilZaobin Chen, Wenmin Chen, Lingqian Zheng, et al.
Current Pharmaceutical Design|July 8, 2024
Corrigendum to: Mechanism of HSP90 Inhibitor in the Treatment of DSS-induced Colitis in Mice by Inhibiting MAPK Pathway and Synergistic Effect of Compound Sophorae DecoctionYuyi Yuan, Hui Wu, Bo Shuai, et al.
Current Pharmaceutical Design|August 29, 2024
In-silico Studies and Antioxidant and Neuroprotective Assessment of Microencapsulated Celecoxib against Scopolamine-induced Alzheimer's DiseaseRajendra Herur Vishnumurthy, M Gnana Ruba Priya, Prashant Tiwari, et al.
Current Pharmaceutical Design|August 12, 2024
Nobiletin Regulates Polyinosinic-polycytidylic Acid-induced Inflammation in Macrophages Partially via the PPAR-γ Signaling PathwayYing-Xing Yue, Shan-Shan Huang, Ying-Zheng Weng, et al.
Current Pharmaceutical Design|August 12, 2024
Identification of Potential Inhibitors from Medicinal Plant-based Phytochemicals for the Influential C4 Target of Diabetic Retinopathy by Molecular Docking StudiesVeerachamy Alagarsamy, Mohaideen Thasthagir Sulthana, Viswas Raja Solomon, et al.
Current Pharmaceutical Design|August 23, 2024
Preparation and Characterization of Nanostructured Lipid Carriers (NLCs) Containing Glycyrrhiza glabra Extract for the Treatment of Skin HyperpigmentationAfsaneh Hoseinsalari, Hoda Atapour-Mashhad, Javad Asili, et al.
Current Pharmaceutical Design|August 22, 2024
Correlation between the Atherogenic Index of Plasma and Progression of Non-target Lesion Vascular Disease Following Percutaneous Coronary Intervention using Drug-eluting StentsTian-Hua Hou, Fei Wang, Cui-Jun Hao, et al.
Pageof 1,008